Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients
NCT00312143
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
De Novo Kidney Transplant Recipients
Interventions
DRUG:
Enteric-coated Mycophenolate sodium (EC-MPS)
Sponsor
Novartis